Balance Sheet

Balance Sheet Decomposition
Biorem Inc

Balance Sheet
Biorem Inc

Rotate your device to view
Balance Sheet
Currency: CAD
Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
2
0
4
2
2
4
1
2
2
2
1
3
1
4
4
6
9
4
4
2
5
Cash
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Equivalents
2
0
4
2
2
4
1
1
2
2
1
3
1
4
4
6
9
4
4
2
5
Short-Term Investments
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
3
5
4
4
9
6
10
6
5
5
4
5
9
11
13
6
8
10
12
15
15
Accounts Receivables
3
5
4
4
9
6
10
6
5
5
4
5
9
11
13
6
8
10
12
15
15
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
0
1
0
1
1
1
1
1
1
0
0
1
0
1
0
1
1
1
1
1
3
Other Current Assets
1
0
0
0
1
0
1
0
1
1
0
1
1
1
0
1
1
1
1
2
2
Total Current Assets
6
7
9
7
13
11
12
9
9
8
7
9
11
16
18
14
18
16
18
21
25
PP&E Net
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
1
1
1
2
2
PP&E Gross
0
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
1
1
1
2
2
Accumulated Depreciation
0
0
1
1
1
1
1
2
0
0
0
0
0
0
0
3
3
4
4
4
4
Intangible Assets
0
2
2
2
2
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Goodwill
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
Other Long-Term Assets
0
0
1
0
0
0
0
0
0
0
0
0
0
0
3
3
2
2
2
1
1
Other Assets
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
6
N/A
12
+89%
15
+22%
12
-21%
17
+47%
15
-11%
16
+4%
10
-34%
10
-6%
9
-9%
8
-14%
9
+21%
11
+22%
16
+38%
21
+34%
18
-16%
22
+25%
19
-13%
21
+8%
24
+16%
29
+18%
Liabilities
Accounts Payable
2
3
3
3
5
2
4
3
3
2
2
2
3
4
4
2
2
5
5
6
4
Accrued Liabilities
0
0
0
0
0
2
4
2
1
1
1
1
1
1
2
1
3
3
3
2
2
Short-Term Debt
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
2
2
1
4
2
3
2
0
0
0
0
2
1
1
1
Other Current Liabilities
0
0
0
0
1
0
1
2
2
1
2
2
3
3
2
2
3
4
4
5
8
Total Current Liabilities
3
3
3
3
6
4
10
10
7
8
7
7
9
8
8
6
8
13
13
14
15
Long-Term Debt
2
0
0
0
2
3
0
0
2
0
1
0
0
0
0
0
1
4
3
3
3
Total Liabilities
5
N/A
3
-30%
3
-2%
3
-8%
8
+171%
7
-19%
10
+55%
10
-5%
10
0%
8
-17%
8
-1%
7
-7%
9
+21%
8
-6%
8
-3%
6
-28%
8
+43%
17
+104%
16
-6%
17
+7%
18
+3%
Equity
Common Stock
3
10
13
13
13
13
13
13
13
13
13
14
14
17
17
17
17
5
5
5
5
Retained Earnings
2
1
2
5
6
6
9
14
15
14
16
14
14
12
8
9
7
6
4
2
1
Additional Paid In Capital
0
0
0
1
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
2
Total Equity
2
N/A
9
+450%
11
+31%
9
-25%
9
+3%
9
-3%
6
-35%
1
-89%
0
-92%
1
+1 660%
0
N/A
2
N/A
2
+26%
7
+201%
13
+77%
12
-9%
14
+15%
2
-85%
5
+130%
7
+49%
11
+58%
Total Liabilities & Equity
6
N/A
12
+89%
15
+22%
12
-21%
17
+47%
15
-11%
16
+4%
10
-34%
10
-6%
9
-9%
8
-14%
9
+21%
11
+22%
16
+38%
21
+34%
18
-16%
22
+25%
19
-13%
21
+8%
24
+16%
29
+18%
Shares Outstanding
Common Shares Outstanding
2
10
12
12
12
12
12
13
13
13
13
15
16
38
39
39
39
15
15
16
16